Skip to main navigation Skip to search Skip to main content

Sustained Wnt/β-catenin signaling rescues high glucose induction of transforming growth factor-β1-mediated renal fibrosis

  • Cheng Ho
  • , Pei Hsien Lee
  • , Yung Chien Hsu
  • , Feng Sheng Wang
  • , Yu Ting Huang
  • , Chun Liang Lin*
  • *Corresponding author for this work
  • Chang Gung Memorial Hospital
  • Chang Gung University

Research output: Contribution to journal › Journal Article › peer-review

66 Scopus citations

Abstract

Introduction: Although diabetic nephropathy is attributable to transforming growth factor-β1 (TGF-β1) overproduction in glomer-ular mesangial cells, the biological role of Wnt/β-catenin signaling in controlling high glucose-induced TGF-β1 has not yet been elucidated. Methods: This study found that sustained Wnt/βcatenin signaling was required to protect glomerular mesangial cells from high glucose induction of TGF-β1-mediated fibrosis using in vitro and in vivo diabetic models. Results: High glucose downregulated the Wnt signaling associated with increased TGF-β1 and fibronectin messenger RNA expression in glomerular mesangial cells. Restoring Wnt4, Wnt5a and cytosolic β-catenin levels by transfecting Wnt4, Wnt5a and stable β-catenin alleviated the stimulatory effect of high glucose on c-Jun mediated TGF-β1 fibrosis. Transfection of kinase-active glycogen synthase kinase-3β (GSK-3β) also abrogated high glucose promotion of nuclear c-Jun levels, TGF-β1 and fibronectin messenger RNA expression in mesangial cells. Pharmacological modulation of GSK-3ββ and β β-catenin signaling by recombinant Wnt5a or GSK-3β inhibitor (BIO or LiCl) suppressed high glucose promotion of TGF-β1-mediated fibrosis. Exogenous BIO and SB216763 alleviated TGF-β1-mediated fibrogenic expression in the kidneys of diabetic rats. Immunohistochemistry showed that GSK-3β inhibitor significantly reversed the diabetic attenuation of TGF-β1 and c-Jun coinciding with fibronectin immunoreactivity within glomeruli. Immunofluorescence demonstrated that cells within the glomeruli restored β-catenin expression after BIO and SB216763 treatment in cells within diabetic glomeruli colocalized with fragmented nuclei by 4′,6-diamidino-2- phenylindole staining. Conclusions: Sustained Wnt signaling reduced c-Jun-dependent TGF-β1-mediated fibronectin accumulation in mesangial cells. These findings suggest that modulation of Wnt signaling is a viable alternative strategy to rescue the TGF-β1- mediated fibrotic signaling pathway in diabetic renal injury.

Original languageEnglish
Pages (from-to)374-382
Number of pages9
JournalAmerican Journal of the Medical Sciences
Volume344
Issue number5
DOIs
StatePublished - 11 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Fibrosis
  • Mesangial cells
  • TGF-β1
  • Wnt/β-catenin

Fingerprint

Dive into the research topics of 'Sustained Wnt/β-catenin signaling rescues high glucose induction of transforming growth factor-β1-mediated renal fibrosis'. Together they form a unique fingerprint.

Cite this